Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells
about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesTreatment of solid tumors with immunotoxins.Effects of cellular pharmacology on drug distribution in tissues.Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting.Construction, expression, and characterization of a recombinant immunotoxin targeting EpCAM.Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticalsBotulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells.Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
P2860
Q21129299-9FBACA8B-F14B-4F4C-A613-9A584C663807Q24813585-9ECB3B72-2B97-4BDB-A5C6-B9E76D1A78F0Q34047139-D96846F0-BD48-4A04-A9F7-D26B4641F861Q34389202-CC0D5624-9122-4212-A765-F180821C976FQ34683623-90EBA155-0E73-407D-90C6-4B52ABE865BEQ35556641-47020127-7710-4745-80B1-8A2CC7959EA3Q36060249-CC70760C-CB5A-48E2-BAB2-8FBB548AD818Q36420059-9675025C-78F8-4EDB-B403-63CBB004A192Q36709641-78EC7DC6-D652-4A60-9758-F9604F6B1F26Q36855892-A56B394C-228A-4FB8-9B94-F1A01F7E5607Q37299181-2711CC25-AFAF-4442-A975-B0657C76722AQ38315868-31CEF619-F509-47E9-B497-CD4017C96FC7Q38916529-9FD59D93-EA62-4175-9E26-AF04FE8C9919Q38957698-0D91A1FF-3BFD-4135-9003-BE4312F215FAQ41561905-99B36E9E-BB0D-4416-867A-F44B03EF8E24Q52098663-8201DED9-8FD5-473D-A14A-F5A35550D351
P2860
Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Rate of internalization of an ...... vity against human tumor cells
@ast
Rate of internalization of an ...... vity against human tumor cells
@en
Rate of internalization of an ...... vity against human tumor cells
@nl
type
label
Rate of internalization of an ...... vity against human tumor cells
@ast
Rate of internalization of an ...... vity against human tumor cells
@en
Rate of internalization of an ...... vity against human tumor cells
@nl
prefLabel
Rate of internalization of an ...... vity against human tumor cells
@ast
Rate of internalization of an ...... vity against human tumor cells
@en
Rate of internalization of an ...... vity against human tumor cells
@nl
P2860
P356
P1476
Rate of internalization of an ...... vity against human tumor cells
@en
P2093
R A Reisfeld
U C Wargalla
P2860
P304
P356
10.1073/PNAS.86.13.5146
P407
P577
1989-07-01T00:00:00Z